16th week of 2011 patent applcation highlights part 22 |
Patent application number | Title | Published |
20110091349 | METHOD FOR PRODUCING MAGNESIUM ALLOY PLATE AND MAGNESIUM ALLOY PLATE - The present invention provides a method for producing a magnesium alloy sheet capable of producing a magnesium alloy sheet having excellent plastic workability such as press workability. The method of the present invention includes rolling a magnesium alloy blank with a reduction roll. The rolling includes controlled rolling performed under the following conditions (1) and (2) wherein M (% by mass) is the Al content in a magnesium alloy constituting the blank:
| 2011-04-21 |
20110091350 | METHOD AND APPARATUS FOR FORMING TITANIUM-ALUMINIUM BASED ALLOYS - Disclosed herein are reactors and methods for forming alloys based on titanium-aluminium or alloys based on titanium-aluminium inter-metallic compounds. The reactor comprises a first section having an inlet through which precursor material comprising titanium subchlorides and aluminium can be introduced. The first section is heatable to a first temperature at which reactions between the titanium subchlorides and aluminium can occur, and further comprises a gas outlet via which any gaseous by-product formed can be removed. The reactor also comprises a second section which can be heated to a second temperature at which reactions of material transferred from the first section can occur to form the titanium-aluminium based alloy, a gas driver adapted in use to cause any gaseous by-product formed in the reactions in the second section to move in a direction towards the first section, and an intermediate section between the first and second sections. The intermediate section can be heated to an intermediate temperature at which at least a portion of material transferred from the first section can accrete and form a cake on a surface of the intermediate section and at which gaseous by-product formed in the reactions in the second section can be received and condensed. The reactor also comprises a removing apparatus for removing caked material from the surface of the intermediate section and transferring it to the second section. | 2011-04-21 |
20110091351 | BONDING COMPOSITION - A bonding composition ( | 2011-04-21 |
20110091352 | LIGHT METAL SOLID SOLUTION ALLOYS FOR HYDROGEN STORAGE - A light metal solid solution alloy for reversible hydrogen storage can include a light metal solid solution alloy of M | 2011-04-21 |
20110091353 | Methods for Sterilizing Tissue - Methods are disclosed for sterilizing tissue to reduce the level of one or more active biological contaminants or pathogens therein, such as viruses, bacteria, (including inter- and intracellular bacteria, such as mycoplasmas, ureaplasmas, nanobacteria, chlamydia, rickettsias), yeasts, molds, fungi, prions or similar agents responsible, alone or in combination, for TSEs and/or single or multicellular parasites. The methods involve sterilizing one or more tissues with irradiation. | 2011-04-21 |
20110091354 | ROOM FOGGING DISINFECTION SYSTEM - A system for disinfecting a room includes an enclosure having first and second air inlets and an air intake control assembly to selectably control air flow into the enclosure through the first and second air inlets. Air that flows between the exterior and interior of the enclosure through the second air inlet passes through a filter assembly. The enclosure also includes an air dispersion outlet having a fan that draws air into the enclosure through the first and second air inlets and forces air out of the enclosure. A chemical dispersion assembly generates a disinfecting fog relative to the fan. A system controller controls the air intake control assembly to disperse the disinfecting fog into the room, and subsequently draw the disinfecting fog from the room and through the filter assembly. | 2011-04-21 |
20110091355 | APPARATUS FOR CHEMILUMINESCENT ASSAY AND DETECTION - An apparatus includes a system for guiding chemiluminescence and a system for preventing a variation in dark currents. The apparatus includes a first light shielding BOX having a sample container holder and a shutter unit therein, the shutter unit including a top plate which is partly formed by a movement of a plate member, and a second light shielding BOX having a photodetector therein. While a measurement is not implemented, the shutter unit is closed to block entrance of stray light to the photodetector, and while a measurement is implemented, the plate member is moved to open the shutter unit, and the tip of the photodetector is inserted into a through hole formed in the top plate, so that the distance between the bottom of the sample container and a sensitive area of the photodetector is reduced to several millimeters or less. | 2011-04-21 |
20110091356 | MICRO-FLUIDIC DEVICE AND SAMPLE TESTING METHOD USING THE SAME - A micro-fluidic device containing an anti-coagulant and a sample testing apparatus equipped with the same are provided. The micro-fluidic device includes a sample chamber which receives a sample, an anti-coagulant chamber which receives an anti-coagulant, a channel which communicably connects the sample chamber to the anti-coagulant chamber, and a valve which opens and closes the channel. | 2011-04-21 |
20110091357 | ANALYTICAL SYSTEMS, DEVICES, AND CARTRIDGES THEREFOR - Described here are systems, devices, cartridges, methods, and kits for detecting or quantifying at least two different analytes using at least two different techniques, in a single sample. The cartridges typically comprise at least two test sites and the location of at least one test site is not dependent on a corresponding measurement device. The systems generally comprise a device, memory, and a processing module. The device comprises a light source, an array detector, and a port configured to accept at least a portion of a cartridge. The processing module is configured to perform an image analysis of the cartridge. The methods comprise the steps of acquiring calibration information, acquiring an image of the cartridge, performing an image analysis, and cycling through specific detection or quantification techniques corresponding to the techniques required by the test sites. Computer readable media are also described. | 2011-04-21 |
20110091358 | Wall-mounted aromatic air freshener device - A wall-mounted aromatic air freshener device includes a board, and a housing and a frame, both disposed at a backside of the board, a container disposed in the housing for containing an essential oil, a light emitting element and a light emitting control element, both installed in the frame, a switch device for turning on or off the light emitting element, such that an oil wick can absorb and vaporize an essential oil to disperse an aromatic air, and the light emitting element produces an optical decorative effect, so as to constitute the aromatic air freshener device. | 2011-04-21 |
20110091359 | SMALL CYLINDRICAL REFORMER - Disclosed herein is a small cylindrical reformer, which is suitable for use in the production of hydrogen from fossil fuels for a small fuel cell power plant. In the small cylindrical reformer according to this invention, a reforming reactor, a water gas shift reactor (high temperature or low temperature), a combustor, a heat exchanger, a steam generator, etc., may be integrated in a single container to form an optimal heat exchanging network, minimize heat loss and optimize heat exchange efficiency. Thereby, the reformer is designed to be easily processed and manufactured and to have a compact size, thus realizing high efficiency, light weight and ease of mass production. | 2011-04-21 |
20110091360 | HIGH SHEAR SYSTEM AND PROCESS FOR THE PRODUCTION OF ACETIC ANHYDRIDE - A system and method for a high shear mechanical device incorporated into a process for the production of acetic anhydride as a reactor device is shown to be capable of decreasing mass transfer limitations, thereby enhancing the process. A system for the production of acetic anhydride including the mixing of catalyst and acetic acid via a high shear device. | 2011-04-21 |
20110091361 | Filter for removing particles from a gas stream and method for the manufacture thereof - A filter for removing particles from a gas stream, in particular soot particulate from an exhaust-gas stream of an internal combustion engine, including a filter body composed of a ceramic filter substrate, the filter substrate being coated with a porous protective layer of a coating material. The coating material contains an admixture of 1 to 20% by weight of at least one compound of an element of the second main group, which may be of an oxide of an element of the second main group, and cracks contained in the ceramic filter substrate are partially filled with the coating material. In addition, a method for manufacturing a filter, where the coating material for the porous protective layer is applied to the sintered, ceramic filter substrate, at least one compound of an element of the second main group is added, optionally other substances contained in the protective layer are added, and the porous protective layer is fixed. | 2011-04-21 |
20110091362 | ANIMAL WASTE PROCESSING - A method and apparatus for eliminating mold spores, pathogens and odor from material like equine bedding. The apparatus includes two or more pairs of augers including blades to control the size of the material and to move it in a zigzag fashion through heat. | 2011-04-21 |
20110091363 | VIAL PRESENCE INDICATOR FOR VIAL-BEARING RACK - An indicator for enabling an analytical instrument to positively detect the presence of a vial in respective vial-receiving rack position regardless of whether the vial is oriented in a manner necessary for a code reader to read a code printed on the vial. Translation of a leaf spring upon insertion of a vial into a rack position causes a flag to obscure a code provided adjacent the rack position. An instrument into which the rack is installed interprets the failure of the code reader to detect this code as positive indication that a vial is disposed within the respective rack position. | 2011-04-21 |
20110091364 | APPARATUS FOR DELIVERING PIPETTABLE SUBSTANCES | 2011-04-21 |
20110091365 | PICOLYLAMINE RESINS - The present application relates to novel gel-type or macroporous picolylamine resins which are based on at least one monovinylaromatic compound and at least one polyvinylaromatic compound and/or a (meth)acrylic compound and contain tertiary nitrogen atoms in structures of the general formula (I) | 2011-04-21 |
20110091366 | NEUTRALIZATION OF ACID AND PRODUCTION OF CARBONATE-CONTAINING COMPOSITIONS - Provided are methods and systems for neutralizing acidic solution. In such methods, an acidic solution may be generated and methods of raising the pH of the acidic solution are provided that may utilize rocks or mineral. Methods for processing rocks and minerals for digestion by an acidic solution are described. Digestion products of rocks and minerals are provided. | 2011-04-21 |
20110091367 | GRANULATE HAVING PHOTOCATALYTIC ACTIVITY AND METHODS FOR MANUFACTURING THE SAME - The present invention is directed to a granulate having photocatalytic activity, comprising particles of an inorganic particulate material coated with a photocatalytically active compound for introducing photocatalytic activity into or on building materials. The invention is further related to the manufacture of such a granulate and its use into or on building materials such as cement, concrete, gypsum and/or limestone and water-based coatings or paints for reducing an accumulation and growth of microorganisms and environmental polluting substances on these materials and thus reducing the tendency of fouling, while the brilliance of the colour is maintained and the quality of the air is improved. | 2011-04-21 |
20110091368 | XLi2MgHn HYDRIDES AS HYDROGEN STORAGE COMPOUNDS - State-of-the-art electronic structure calculations yield results consistent with the observed compound SiLi | 2011-04-21 |
20110091369 | METHOD FOR THE RECOVERY OF AMMONIA FROM A GASEOUS STREAM IN A SYNTHESIS PROCESS OF UREA - The present invention relates to a process for the recovery of ammonia contained in a gaseous purging stream produced in a synthesis process of urea, comprising the following phases: a) subjecting the gaseous purging stream to a washing with an aqueous acidic solution, at a pH ranging from 1 to 6, with the formation of a first purified gaseous stream and an aqueous solution containing an ammonium salt; b) subjecting the aqueous solution containing the ammonium salt coming from phase a) to stripping, after treatment with a strong base, at a temperature ranging from 50 to 250° C. and a pressure ranging from 1 to 40 absolute bar, with the formation of a second gaseous stream comprising NH | 2011-04-21 |
20110091370 | Mechanochemical Synthesis of Carbon Fluorides and an Electrochemical Cell using the Synthesized Carbon Fluorides - Carbon fluoride is synthesized by reactively or high intensity/energy milling at ambient room temperature carbon-containing material (such as graphite, carbon black, coke, or other carbon-based material) with an inorganic fluoride agent (such as cobalt trifluoride) other than fluorine gas. The following chemical reaction occurs: xC+CoF | 2011-04-21 |
20110091371 | SOLUBLE HOMO- AND HETEROMETALLIC COORDINATION POLYMERS BASED ON THE OXALATE LIGAND AND METHOD FOR OBTAINING SPINELS FROM THEM - Soluble homo and heterometallic coordination polymers based on the oxalate ligand and method for obtaining spinels from them. Homo or heterometallic coordination polymers comprising at least one oxalate ligand are characterised by comprising also at least one organic molecule that can stabilise extended structures of metal complexes by the formation of supramolecular interactions so that this polymer is substantially water-soluble and insoluble in organic solvents. These polymers, when in solid state, can generate spinel-type metal oxides or other mixed oxides after thermal oxidation treatment comprising the steps of preparing an alcohol solution of a metal complex comprising at least one oxalate ligand and a metal salt, precipitate this metal complex and this metal salt with a cryptand-type molecule by formation of a coordination polymer which is water-soluble and insoluble in organic solvents, separate the precipitate obtained in the previous step and heat it under oxidising atmosphere at a temperature of at least 350° C. until the spinel or the mixed oxide are formed. | 2011-04-21 |
20110091372 | Dual Variable Domain Immunoglobulins and Uses Thereof - The present invention relates to engineered multivalent and multispecific binding proteins, methods of making, and specifically to their uses in the prevention, diagnosis, and/or treatment of disease. | 2011-04-21 |
20110091373 | PAA NANOPARTICLES FOR ENHANCEMENT OF TUMOR IMAGING - A composition comprising PAA nanoparticles containing a post loaded tetrapyrollic photosensitizer and an imaging agent and methods for making and using same. | 2011-04-21 |
20110091374 | CONTRAST AGENTS FOR APPLICATIONS INCLUDING PERFUSION IMAGING - The present invention is directed, in part, to compounds and methods for imaging the central nervous system or cancer, comprising administering to a subject a contrast agent which comprises a compound that binds MC-I, and an imaging moiety, and scanning the subject using diagnostic imaging. | 2011-04-21 |
20110091375 | USE OF THE COMBINATION COMPRISING TEMOZOLOMIDE AND TNF-ALPHA FOR TREATING GLIOBLASTOMA - Disclosed are methods of synergistically inhibiting growth of a glioma cell comprising contacting the cell with temozolomide and TNFα, or with temozolomide, TNFα, and radiation. Also disclosed are methods of synergistically inhibiting growth of a glioma in a human cancer patient comprising administering temozolomide and TNFα, or with temozolomide, TNFα, and radiation. Pharmaceutical combinations and therapeutic combinations suitable for use in the methods of the invention are also disclosed. | 2011-04-21 |
20110091376 | CATATONIC STEROID ANTIMICROBIAL DIAGNOSTIC, DETECTION, SCREENING AND IMAGING METHODS - The invention relates to diagnostic, detection, screening and imaging methods. In various embodiments, methods of diagnosis, detection, screening and imaging include administering a cationic steroid antimicrobial or CSA to a subject having or at risk of having an infection or a hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) in an amount effective to diagnose or detect the infection or the hyperproliferative disorder (e.g., a tumor, cancer or neoplasia) in the subject. In a particular aspect, a detectable CSA, namely CSA-13 labeled with | 2011-04-21 |
20110091377 | BIOMARKERS FOR MELANOMA - The present invention relates to methods of determining melanoma status in a subject. The invention also relates to kits for determining melanoma status in a subject. The invention further relates to methods of identifying biomarkers and correlating biomarker expression to melanoma status or stage in a subject. | 2011-04-21 |
20110091378 | Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists - The present invention relates methods and compositions for treating interleukin-17 (IL-17) related conditions, such as IL-17A or IL-17F, or muteins thereof in patients having fibrosis using IL-17 antagonists, such as small molecule IL-17 antagonists or protein IL-17 antagonists, such as antibodies, including specified portions or variants, specific for at least one IL-17 protein, mutein or fragment thereof, including therapeutic formulations, administration and devices. | 2011-04-21 |
20110091379 | METHOD FOR TREATING TUMORS AND THEIR METASTASES - The invention relates to a medicament against tumors and their metastases, which preferentially settle in bone tissue, comprising active ingredient at least one binding molecule that binds to bone sialoprotein or a fragment thereof in serum or plasma. | 2011-04-21 |
20110091380 | CHLOROTOXINS AS DRUG CARRIERS - The present invention relates to the use of a toxin moiety (e.g., a chlorotoxin moiety) as a carrier for therapeutic agents, e.g., therapeutic agents that require intracellular uptake to exert their effects. For example, in some embodiments, the present invention provides conjugates comprising a toxin (e.g., a chlorotoxin) moiety and an anti-cancer moiety and methods for using such conjugates to increase cellular uptake and/or increase specificity for cancer cells of the anti-cancer drug. In some embodiments, the present invention provides conjugates comprising a toxin moiety (e.g., a chlorotoxin moiety) and a nucleic acid agent. Also provided are methods of treatment involving administration of such conjugates, and pharmaceutical compositions and kits useful for carrying out such methods of treatment. | 2011-04-21 |
20110091381 | GABA BIOMARKERS FOR DEPRESSION - Differential expression of nucleic acids in the brains of subjects suffering from late-onset depression has been demonstrated. The invention provides methods useful in the determination of late-onset depression. Also provided by the present invention is a screening method for the identification of compounds for treatment, prevention or diagnosis of late-onset depression. | 2011-04-21 |
20110091382 | NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION - Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled flavones, coumarins, carbazoles, quinolinones, chromenones, imidazoles and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease. | 2011-04-21 |
20110091383 | FENRETINIDE DERIVATIVES AND USES THEREOF AS THERAPEUTIC, DIAGNOSTIC AND IMAGING AGENTS - Synthetic peptidomimetic derivatives and phenyl group derivatives of Fenretinide (4-HPR) are disclosed, as are their uses as therapeutic, diagnostic and imaging agents for cancer and other diseases. | 2011-04-21 |
20110091384 | Biomarker for identification of melanoma tumor cells - This invention relates to use of neuropilin-2 as a novel biomarker and therapeutic target for melanoma. The presence of neuropilin-2 can be used as a biomarker for diagnosing and detecting individuals suffering from or at risk for developing melanoma. Also described are methods of using neuropilin-2 to capture circulating melanoma cells. The present invention further relates to methods of treating an individual suffering from or at risk for developing melanoma with an agent that inhibits the activity of neuropilin-2. | 2011-04-21 |
20110091385 | SUBSTITUTED ARYL PIPERIDINYLALKYNYLADENOSINES AS A2AR AGONISTS | 2011-04-21 |
20110091386 | HUMANIZED ANTIBODIES SPECIFIC FOR AMINO ACID SEQUENCE RGD OF AN EXTRACELLULAR MATRIX PROTEIN AND THE USES THEREOF - The present invention provides humanized antibodies that immunospecifically recognize the RGD sequence. Some of these antibodies inhibit the biological functions of the RGD proteins, thereby exhibiting therapeutic effects on various disorders or diseases that are associated with RGD proteins, including cancer, e.g., the growth and metastasis of a cancer cell, and inflammatory diseases, e.g., rheumatoid arthritis, osteoarthritis, hepatitis, endometriosis, bronchial asthma, fibrosis, diabetes, arteriosclerosis, multiple sclerosis, granuloma, an inflammatory bowel disease (ulcerative colitis and Crohn's disease), an autoimmune disease, and so forth. | 2011-04-21 |
20110091387 | METHODS AND COMPOSITIONS FOR REDUCING SKIN DAMAGE - The RhoE GTPase pathway has been identified as a target for screening and treatment methods for the prevention and/or reduction of short- and long-term UVB-induced skin damage, e.g., the prevention and/or reduction of UVB-induced wrinkles. The invention thus features screening and treatment methods for prevention or reduction of UVB-induced sin damage, and related compositions, e.g., cosmetic compositions. | 2011-04-21 |
20110091388 | USE OF PDE7 INHIBITORS FOR THE TREATMENT OF MOVEMENT DISORDERS - A method of treating a movement abnormality associated with the pathology of a neurological movement disorder, such as Parkinson's disease or Restless Leg(s) Syndrome by administering a therapeutically effective amount of a PDE7 inhibitory agent. An aspect of the invention provides for the administration of a PDE& inhibitory agent in conjunction with a dopamine agonist or precursor, such as levodopa. In another aspect of the invention, the PDE7 inhibitory agent may be selective for PDE7 relative to other molecular targets (i) known to be involved with the pathology of Parkinson's disease or (ii) at which other drug(s) that are therapeutically effective to treat Parkinson's disease act. | 2011-04-21 |
20110091389 | PARTICLES WITH RADIATION ACTIVATED ADHESIVE - Techniques are generally described for particles with a surface including an adhesion material. The adhesion material may be selectively activated in response to radiation. The particles may be distributed proximate to a target through a fluid system. Radiation may be emitted toward the target causing the adhesion material to activate. The activated adhesive material on the surface of the particles may adhere to the target providing a fiducial mark or reference point. The fiducial mark may be visible through a medical imaging technique. In some examples, the particles may be nanoparticles. In some examples, the radiation may be infrared radiation. | 2011-04-21 |
20110091390 | WATER SOLUBLE TETRAPYROLLIC PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY - A tetrapyrollic photosensitizer compound having at least one pendant —CH | 2011-04-21 |
20110091391 | DISCRETE TUNABLE SENSING ELEMENTS AND COMPOSITIONS FOR MEASURING AND REPORTING STATUS AND/OR PRODUCT PERFORMANCE - Discrete sensing elements are described that can be integrated into dental hygiene products and can provide rapid and direct feedback to a user as to oral environmental status and as to the performance of the intended oral care product. Selectively tuned elements can both sense and report relevant information including usage time, adequacy of performance during use, training for better usage, and/or the physical or biological status as can be measured by direct oral contact. Sensing and reporting mechanisms can be tuned for increased or decreased sensitivities. Sensing elements can comprise one or more discrete optical changes, structural changes, or other physical changes to the dental hygiene product as a means of alerting a user of a stimulus. Use of optical reference colors provides a high level of accuracy and objectivity as to the status of a sensing event. Enabling delivery and application compositions and methods are described. | 2011-04-21 |
20110091392 | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF INFECTIONS OF THE ORAL CAVITY - The present invention relates to compositions comprising benzophenanthridine alkaloids, benzofuran compounds and catechin polyphenols, which are useful in the treatment and prevention of infections of the oral cavity. | 2011-04-21 |
20110091393 | EXOTHYLATE-FREE PERSONAL CARE CLEANSING COMPOSITIONS - Provided are personal care cleansing compositions that are substantially ethoxylate free, especially a personal care composition, comprising: hydroxypropyl methyl cellulose having a hydroxypropyl MS of about 0.8 or greater and a methoxyl DS of about 2 or greater; and an alkyl polyglycoside surfactant. | 2011-04-21 |
20110091394 | High-Purity Rebaudioside D And Low-Calorie Tooth Paste Composition Containing The Same - The invention provides methods of purifying Rebaudioside D from the | 2011-04-21 |
20110091395 | EXTRACT OF PHALERIA MACROCARPA AS AN ANTINEOPLASTIC, ANTI-INFLAMMATORY AND ANTIANGIOGENIC AGENT - A pharmaceutical dosage form comprising an extract of | 2011-04-21 |
20110091396 | SUNLESS TANNING COMPOSITION INSURING EFFECTIVE APPLICATION TO SKIN - A sunless tanning composition is provided with from 0.1 to 40% of a C | 2011-04-21 |
20110091397 | STABLE WATER-IN-OIL EMULSION SYSTEM - A water-in-oil emulsion system is provided that includes a water phase, an oil phase, a water-in-oil emulsifier of 1-5 wt % on the basis of the total amount of the system, a solid powder of 0.1-20 wt % on the basis of the total amount of the system and a cationic surfactant of 0.01-2 wt % on the basis of the total amount of the system. The cationic surfactant is a quaternary ammonium salt represented by the general formula R1R2R3R4N+X−, in which R1, R2, R3 and R4 are each independently a C1-C28 alkyl group or a C1-C28 alkyl group substituted by a C1-C4 acyl group, a C2-C4 acyloxy group, a hydroxy group or a C2-C4 alkenyl group, and X− is an anion. | 2011-04-21 |
20110091398 | OLEANOYL PEPTIDE COMPOSITION AND A METHOD OF TREATING SKIN AGING - The present invention relates to a composition containing peptide of SEQ ID No. 1 linked to oleanolic acid and a method of treating skin aging. The composition effectively reduces signs of ageing due to oxidation, collagen insufficiency and excess activity of serine proteases like elastase and collagenase that result in wrinkling of skin, fine expression lines, reduced skin thickness, hyperpigmentation, under eye dark circles, and premature ageing. | 2011-04-21 |
20110091399 | USE OF ORGANO-MODIFIED SILOXANE BLOCK COPOLYMERS FOR PRODUCING COSMETIC OR PHARMACEUTICAL COMPOSITIONS - The invention relates to emulsifier systems comprising organomodified siloxane block copolymers, their use, in particular the preparation of cosmetic, dermatological or pharmaceutical formulations, and of care and cleaning compositions, and also the products themselves prepared with the help of emulsifier systems. | 2011-04-21 |
20110091400 | COSMETIC EMULSIFIER COMBINATION - The invention relates to a cosmetic composition comprising a) sodium stearyl glutamate, b) a crosslinked polymer of vinylpyrrolidone and acrylic acid. | 2011-04-21 |
20110091401 | NOVEL WATER-RESISTANT SUNSCREEN COMPOSITION - The present invention is directed to sunscreen composition comprising: (a) at least one oil- and water repellent emulsifier chosen from polyperfluoroethoxymethoxy difluoroethyl PEG phosphate; (b) at least one hydrophobically-modified emulsifier chosen from inulin lauryl carbamate; (c) at least one gelling agent; and (d) sunscreen actives, and wherein the composition is water-resistant, while not requiring the use of a film-former, and is a stable emulsion. | 2011-04-21 |
20110091402 | ANTIPERSPIRANT PRODUCTS AND PROCESSES FOR FABRICATING THE SAME - Antiperspirant products and processes for making them are provided. In one embodiment, an antiperspirant product comprises an active antiperspirant compound and a carrier having a first volatility rate in an air ambient at about 50° C. and 1 atm after a first time period and a second volatility rate in an air ambient at about 50° C. and 1 atm after a second time period, wherein the second volatility rate is less than the first volatility rate and the first time period is less than the second time period. | 2011-04-21 |
20110091403 | OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE - Methods for using compositions comprising oligosaccharide aldonic acids for general care, as well as for treatment and prevention, of various cosmetic conditions and dermatological disorders, including those associated with intrinsic and/or extrinsic aging, as well as with changes or damage caused by extrinsic factors; general care, as well as treatment and prevention of diseases and conditions, of the oral, and vaginal mucosa; for general oral care, as well as treatment and prevention of oral and gum diseases; and for wound healing of the skin. Methods may comprise using compositions comprising oligosaccharide aldonic acids and additional cosmetic, pharmaceutical or other topical agents to enhance or create synergetic effects. | 2011-04-21 |
20110091404 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE - The invention relates to the use of n-hexadecyl n-nonanoate (CAS number 72934-15-7, hereafter cetyl nonanoate) and n-octadecyl n-nonanoate (CAS number 107647-13-2, hereafter stearyl nonanoate) and to the mixtures thereof (CAS number 878027-13-5) as fixatives for fragrance substances. The invention also relates to specific compositions comprising (A) cetyl nonanoate and/or stearyl nonanoate as well as (B) one or more fragrance substances. The invention also relates to a process for the preparation of such compositions as well as to (cosmetic) products comprising a composition according to the invention. The invention further relates to a process for imparting, intensifying or modifying an odor on (human) skin. A particular aspect of the present invention relates to the improvement in the adhesive strength of a composition according to the invention on (human) skin and/or (human) hair. | 2011-04-21 |
20110091405 | COMPOSITION AND METHODS FOR PROMOTING LUSH HAIR GROWTH - Compositions, kits and methods are provided for conditioning, revitalizing, volumizing or increasing the natural pigmentation of the hair, including hair on the scalp, eyelashes, eyebrows, mustache and beard, promoting healthy growth, and treating and preventing loss, thinning or miniaturization of hair due to aging, various genetic, pathological, radiation, chemotherapy, chemical treatment, environmental or other reasons. | 2011-04-21 |
20110091406 | COMPOSITION AND METHOD FOR PROTECTING LABILE ACTIVE COMPONENTS DURING HIGH TEMPERATURE DRYING - A composition and method for protecting personal care components, advantageously labile active personal care components, from decomposition during high temperature drying, employing water-soluble hydrolyzed polysaccharide encapsulants. Also disclosed is an additive for a personal care composition comprising a personal care component that is at least partially encapsulated within a hydrolyzed polysaccharide encapsulant. Also disclosed is a method for protecting a composition containing labile biologically active particles which comprises encapsulating at least a portion of the biologically active particles within hydrolyzed polysaccharide particles, thereby protecting said portion of said biologically active particles. | 2011-04-21 |
20110091407 | POLYMER DERIVED FROM LINEAR POLYETHYLENIMINE FOR GENE TRANSFER - The invention relates to a static copolymer of linear polyethylenimine that comprises two monomer units of the following formulas I and II, in which R | 2011-04-21 |
20110091408 | METHODS OF USING FLUOROALKYL PHOSPHATE COMPOSITIONS - Fluoroalkyl phosphates containing a tertiary carbon and a nonfluorinated chain are useful as surfactants and additives. The f can be used to alter a surface property of a medium and to provide resistance to blocking, open time extension, or oil repellency to a substrate. | 2011-04-21 |
20110091409 | ARTIFICIAL TERMITE EGG HAVING BETA-GLUCOSIDASE AS TERMITE EGG RECOGNITION PHEROMONE, AND CONTROL OF TERMITES USING THE SAME - The present invention provides a mimetic egg comprising β-glucosidase, a salt thereof, a biological fragment thereof or a β-glucosidase-related peptide as an egg recognition pheromone in its base material mimicking an egg of a insect pests, particularly a termite, a method for exterminating and controlling insect pests, and a tool for a biological study using the same. | 2011-04-21 |
20110091410 | Engineered CXCL12 Alpha Locked Dimer Polypeptide - The present invention provides a novel CXCL12-α | 2011-04-21 |
20110091411 | Interleukin-1 Muteins Linked to Virus-Like Particles to Treat IL-1 Associated Diseases - The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen array, wherein the antigen is an IL-1 mutein. More specifically, the invention provides a composition comprising a virus-like particle, and at least one IL-1 mutein linked thereto. The invention also provides a process for producing the composition. The compositions of the invention are useful in the production of vaccines for the treatment of inflammatory diseases, and chronic autoimmune diseases, genetic diseases and cardiovascular diseases. The composition of the invention efficiently induces immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context. | 2011-04-21 |
20110091412 | MUTANT INTERLEUKIN-2 (IL-2) POLYPEPTIDES - The present invention relates to mutant IL-2 polypeptides that act as receptor antagonists. The mutant IL-2 polypeptides bind CD 25 but do not activate the IL-2 receptor. Also provided are methods of using the mutant IL-2 polypeptides, for example, to treat a patient who has cancer or a viral infection. The mutant polypeptides can also be used in various delivery systems. | 2011-04-21 |
20110091413 | THERAPEUTIC USE OF INTERLEUKIN-2 MUTANTS - Interleukin-2 (IL-2) mutants having reduced toxicity, which include full-length IL-2, truncated forms of IL-2 and forms of IL-2 that are linked to another molecule are disclosed herein. Particular substitutions within IL-2, particularly within the permeability enhancing peptide region of IL-2 achieve substantial reduction of vasopermeability activity as compared to a wildytpe form of the mutant IL-2 while retaining many of the immune activating properties of IL-2. Invention IL-2 mutants can be used to stimulate the immune system of an animal and may be used in the treatment of various disorders and conditions. | 2011-04-21 |
20110091414 | STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY - Compositions of proteins having free thiols, and methods of making and using such compositions, are described. | 2011-04-21 |
20110091415 | Hydroxyethyl Starch-Containing Polypeptide Compositions - The invention provides compositions containing hydroxyethyl starch and polypeptides, including therapeutic polypeptides such as interleukin-11, that provide for enhanced stability of the polypeptide following storage at room temperature or elevated temperatures. | 2011-04-21 |
20110091416 | IMMUNOGLOBULIN FUSION PROTEINS - Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules. | 2011-04-21 |
20110091417 | Interleukin-22 Polypeptides, Nucleic Acids Encoding The Same And Methods For The Treatment Of Pancreatic Disorders - The present invention is directed to interleukin-22 polypeptides and nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. | 2011-04-21 |
20110091418 | METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS - Methods for treating viral infections using polyamine analogs, including mitoguazone (MGBG), are provided. In these methods, polyamine analogs destroy macrophages that act as viral reservoirs, facilitating the destruction of the viruses that dwell within the macrophages. Examples of viral infections that may be treated with the present methods include, but are not limited to, infections from human immunodeficiency viruses. These methods differ from previous methods of treatment using polyamine analogs, wherein the polyamine analogs were administered only as anti-tumor agents. | 2011-04-21 |
20110091419 | Use of Pegylated IL-10 to Treat Cancer - Provided are methods of treatment for tumors. In particular, methods are provided for use of a chemically modified IL-10 to treat tumors. | 2011-04-21 |
20110091420 | Injectable Sustained-Release Pharmaceutical Formulation and the Preparation Method Thereof - Disclosed are an injectable sustained-release pharmaceutical formulation and a process for preparing the same. In some embodiments, the formulation comprises an active ingredient in a therapeutically effective amount, an amphipathic molecule, an organic acid and/or a salt thereof which is hardly soluble in water, and an oily solvent. The injectable sustained-release pharmaceutical formulation provides a good sustained-release effect for various active ingredients, in particular peptides, proteins, nucleic acids and saccharides. | 2011-04-21 |
20110091421 | Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases - The present invention discloses multiple treatment regimens for vascular-related diseases and disorders. The present invention provides for methods of treating vascular-related disorders based on gene expression studies from samples collected from individuals having symptoms of vascular-related disorders. Additionally, methods are disclosed involving diagnostic techniques to focus treatment regimens. Finally, methods of treating vascular-related disorder involving targeting microRNAs are also disclosed. | 2011-04-21 |
20110091422 | Use of Genetic Markers for Identifying the Response to Interferon Treatment in Multiple Sclerosis Patients - The present invention relates to the use of genetic markers to identify the response to interferon-beta (IFN-beta) treatment in Multiple Sclerosis (MS) patients as well as a method for treating MS patients and kits for genotyping. | 2011-04-21 |
20110091423 | COMPOSITIONS AND METHODS OF USE OF RITONAVIR FOR TREATING HCV - The present invention discloses compositions and a method of improving the pharmacokinetics of pharmaceutical agents (or pharmaceutically acceptable salts, esters, and prodrugs thereof) which are metabolized by cytochrome P450 monoxygenase comprising coadministering ritonavir or a pharmaceutically acceptable salt, ester, and prodrug thereof. | 2011-04-21 |
20110091424 | ORAL DOSAGE COMPOSITION - The present invention is an oral dosage composition for prevention and treatment of hepatic inflammation such as NASH. The present invention is an oral dosage composition for prevention or treatment of hepatic inflammation, contains the radical scavenging active spirulina powder effective in preventing, ameliorating, and curing NASH or the like. | 2011-04-21 |
20110091426 | Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38- bone marrow stem cells - A novel co-culture system using human brain endothelial cells (HUBEC) which promotes the expansion of human CD34 | 2011-04-21 |
20110091427 | METHODS FOR TREATING A KIDNEY INJURY - Provided herein are methods of treating a kidney injury in a patient, comprising administering to the patient hematopoietic stem cells (HSCs) in an amount effective to treat the kidney injury. In some embodiments, administration of the HSCs is delayed, such that the HSCs are not administered immediately after the kidney injury. In certain aspects, the HSCs are administered to the patient during the beginning of the repair phase of the kidney. Further embodiments and aspects of the invention, including related methods and compositions for use therein, are described herein. | 2011-04-21 |
20110091428 | COMPOSITIONS OF ADULT ORGAN STEM CELLS AND USES THEREOF - Compositions of isolated adult organ stem cells, including hematopoietic stem cells, cardiac stem cells, and kidney stem cells, are disclosed. In particular, the present invention provides c-kit positive, lineage negative adult stem cells that can be isolated from adult organ tissue. Such stem cells are capable of generating all the cell lineages of the organ tissue from which they were isolated. Methods for repairing damaged organ tissue with the isolated organ stem cells are also disclosed. | 2011-04-21 |
20110091429 | Methods for Enhancing Stem Cell Engraftment During Transplantation - The present invention relates to the fields of hematopoietic stem cell transplantation and molecular biology. More specifically, methods for improving engraftment efficiency in stem cell transplants by improving stem cell homing to bone marrow are provided. | 2011-04-21 |
20110091430 | MESENCHYMAL STEM CELLS AND METHODS OF USE THEREOF - The invention provides compositions and methods of enhancing the viability of primary stem cells and enhancing the engraftment of transplanted stem cells into a mammalian recipient. Accordingly, the invention includes a method of regenerating a mesenchymally-derived tissue by contacting the tissue with a composition containing an isolated adult mesenchymal stem cell, which are apoptosis-resistant. The mesenchymal stem cell is an adult cell obtained from an adult bone marrow. | 2011-04-21 |
20110091431 | COMPOSITIONS AND METHODS COMPRISING PEDIOCOCCUS FOR REDUCING AT LEAST ONE SYMPTOM ASSOCIATED WITH AUTISM SPECTRUM DISEASE IN A PERSON DIAGNOSED WITH AN AUTISM SPECTRUM DISEASE - Compositions, methods, etc., comprising | 2011-04-21 |
20110091432 | ISOLATED PEDIOCOCCUS ACIDILACTICI 05B0111 AND METHOD OF PRODUCING EXOPOLYSACCHARIDE - Disclosed herein is an isolated | 2011-04-21 |
20110091433 | TREATMENT USING REPROGRAMMED MATURE ADULT CELLS - A method of treating various diseases, disorders, or conditions in patient using reprogrammed cells such as retrodifferentiated, transdifferentiated, or redifferentiated cells. The method comprises obtaining committed cells from the patient, retrodifferentiating the committed cells to obtain retrodifferentiated target cells, and administering the retrodifferentiated cells to the patient. In certain embodiments, the method comprises obtaining committed cells from the patient, transdifferentiating the committed cells to obtain transdifferentiated target cells, and administering the transdifferentiated target cells to the patient. The retrodifferentiated or transdifferentiated target cells repair or replenish tissue or cells in the patient. | 2011-04-21 |
20110091434 | AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSYLTRANSFERASE - Disclosed are methods, compositions of matter, and kits useful for augmentation of homing and engraftment of stem, progenitor and mature cells through modification of cellular membrane properties following ex vivo treatment. The methods, compositions, and cells may be used for the treatment of a wide variety of disorders in which augmentation of cell trafficking, homing and engraftment is desired. | 2011-04-21 |
20110091435 | PHYTOESTROGENIC FORMULATIONS FOR ALLEVIATION OR PREVENTION OF HAIR LOSS - Select phytoestrogen pharmaceutical compositions and methods of use for preventing or reducing one or more symptoms associated with hair loss or prostate cancer/prostate hypertrophy are described herein. These select phytoestrogen formulations are preferably composed only of two or more plant-derived estrogenic molecules and/or their structural analogues and exhibit binding preference to ERβ over ERα and agonist activity in non-reproductive tissues including brain. | 2011-04-21 |
20110091436 | USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTIC TREATMENTS - The present invention relates to the use of matrix metalloproteinase MMP-10 in the preparation of a pharmaceutical composition useful for thrombolytic therapy, it also being possible for said composition to contain a plasminogen activator. Additionally, the present invention relates to said pharmaceutical composition for the treatment of thrombotic disorders. | 2011-04-21 |
20110091437 | FUSION PROTEINS - A single chain, polypeptide fusion protein, comprising: a non-cytotoxic protease, or a fragment thereof, which protease or protease fragment is capable of cleaving a protein of the exocytic fusion apparatus of a nociceptive sensory afferent; a dynorphin Targeting Moiety that is capable of binding to a Binding Site on the nociceptive sensory afferent, which Binding Site is capable of undergoing endocytosis to be incorporated into an endosome within the nociceptive sensory afferent; a protease cleavage site at which site the fusion protein is cleavable by a protease, wherein the protease cleavage site is located between the non-cytotoxic protease or fragment thereof and the dynorphin Targeting Moiety; and a translocation domain that is capable of translocating the protease or protease fragment from within an endosome, across the endosomal membrane and into the cytosol of the nociceptive sensory afferent. Nucleic acid sequences encoding the polypeptide fusion proteins, methods of preparing same and uses thereof are also described. | 2011-04-21 |
20110091438 | RADIOPROTECTIVE SOD SOLUBLE ISOFORM AND USES THEREOF - The invention refers to a specific isoform of MnSOD (Mn-superoxide dismutase) and its uses for protecting and curing subjects exposed to radiations, specifically space radiations. | 2011-04-21 |
20110091439 | COSMETIC USE OF ACID CERAMIDASE TYPE PROTEINS - A method for preventing and/or treating the signs of skin aging comprises administering as an agent into an individual in need thereof an effective amount of acid ceramidase, polypeptides derived from this protein or analogues thereof, a nucleic sequence encoding such a polypeptide, or an agent for modulating the expression or the biological or biochemical activity of such a polypeptide. A methods for characterizing a state of an epithelium comprises determining a content of acid ceramidase, polypeptides derived from this protein or analogues thereof, or a nucleic sequence encoding such a polypeptide in an epidermis sample. | 2011-04-21 |
20110091440 | Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases - A composition and method for the treatment of Alzheimer's disease and related amyloid plaque development and reduction of amyloid plaque, amyloidosis and amyotrophic lateral sclerosis, as well as neuro-degenerative diseases and protein aggregation diseases, includes an effective amount of a compound selected from the group consisting of phytic acid (inositol hexakisphosphate), a phytate salt, an isomer or hydrolysate of phytic acid or a phytate salt, or a mixture of any combination thereof, being administered to a person in an amount from about 0.5 grams to about 18.75 grams per day, with or without a dephosphorylating enzyme. | 2011-04-21 |
20110091441 | MEGANUCLEASE VARIANTS CLEAVING A DNA TARGET SEQUENCE FROM THE HUMAN INTERLEUKIN-2 RECEPTOR GAMMA CHAIN GENE AND USES THEREOF - An I-CreI variant, wherein at least one of the two I-CreI monomers has at least two substitutions, one in each of the two functional subdomains of the LAGLIDADG core domain situated respectively from positions 26 to 40 and 44 to 77 of I-CreI, said variant being able to cleave a DNA target sequence from the human IL2RG gene. Use of said variant and derived products for the prevention and the treatment of X-linked severe combined immunodeficiency. | 2011-04-21 |
20110091442 | NOVEL COMPOSITIONS FOR PREVENTING AND/OR TREATING LYSOSOMAL STORAGE DISORDERS - The present invention provides novel compositions as well as methods for preventing and/or treating lysosomal storage disorders. In particular, the present invention provides methods for preventing and/or treating Gaucher's disease. | 2011-04-21 |
20110091443 | HEPARIN-CONJUGATED FIBRIN GEL AND METHOD AND KIT FOR PREPARING SAME - A method of preparing a heparin-conjugated fibrin gel is provided, which includes activating heparin, conjugating the activated heparin with fibrinogen to prepare heparin-conjugated fibrinogen, mixing free fibrinogen with the heparin-conjugated fibrinogen to prepare a fibrinogen mixture, and mixing thrombin with the fibrinogen mixture. In addition, a heparin-conjugated fibrin gel prepared by the above method and a kit for preparing the same are provided. According to the method of preparing the heparin-conjugated fibrin gel, the heparin-conjugated fibrin gel having an affinity for drugs such as growth factors may be easily prepared at low costs, and can also be used as a therapeutic drug excellently effective on generation of tissues such as bones, skin, blood vessels, cartilages, etc. by sustainably releasing drugs such as growth factors to a local site for a long period of time through injection into a human body. | 2011-04-21 |
20110091444 | Methods and compositions for treatment and prevention of major depressive disorder - The present invention relates to methods of diagnosing, prognosing or treating diseases or disorders in which elevated levels of Abeta protein, including abeta | 2011-04-21 |
20110091445 | MODULATION OF INTESTINAL FLORA OF HIV PATIENTS - The present invention is in the field of nutrition for HIV-infected subjects and concerns methods and composition comprising dietary fiber for the normalization of the intestinal flora of HIV-infected subjects. | 2011-04-21 |
20110091446 | SINGLE DOMAIN ANTIBODIES CAPABLE OF MODULATING BACE ACTIVITY - The present invention relates to single domain antibodies with a specificity for BACE1. More specifically, the invention provides single variable domain antibodies derived from camelids which bind to BACE1 and are capable of inhibiting the activity of BACE1. Said antibodies can be used for research and medical applications. Specific applications include the use of BACE1 specific antibodies for the treatment of Alzheimer's disease. | 2011-04-21 |
20110091447 | LYMPHOCYTE CONTROL OF OBESITY AND INSULIN RESISTANCE - Methods for the treatment, inhibition, prevention, etc. of metabolic syndrome (MetSyn) and/or Type-2 diabetes (T2D) using a T cell activating antibody that stimulates activation and immunomodulation of T-cells to affect the immune environment of adipose tissue and improve insulin sensitivity. Also methods for the treatment, inhibition, prevention, amelioration, reversal, etc., of metabolic syndrome (MetSyn) and/or Type-2 diabetes (T2D) using leukemia inhibitory factor (LIF), or a functional portion thereof. Compositions administered to individuals having or at risk of developing MetSyn and/or T2D may include pharmaceutical compositions. Methods may also provide tolerogenic vaccines based on the administration of identified auto-antigens from individuals having or at risk of developing MetSyn and/or T2D. | 2011-04-21 |
20110091448 | METHODS FOR REGULATION OF STEM CELLS - Methods are provided for increasing stem cells, hematopoietic progenitor/stem cells, mesenchymal progenitor/stem cells, mesodermal progenitor/stem cells, muscle progenitor/stem cells, or neural progenitor/stem cells in vivo in a mammalian subject. Methods are also provided for treating an immune related disease, a mesenchymal/mesoderm degenerative disease, or a neurodegenerative disease in a mammalian subject in need thereof. | 2011-04-21 |
20110091449 | Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies - This invention relates to compositions and methods for the use of anti-autoimmune reagents that specifically bind to anti-desmoglein antibodies, which are responsible for pemphigus foliaceus. In addition, the invention relates to methods and compositions for inhibiting the expression or function of a variable region of an anti-desmoglein (anti-Dsg) pathogenic autoantibody. | 2011-04-21 |